CDKL2
Cyclin-dependent kinase-like 2
Also known as: CDKL2_HUMAN, KKIAMRE, P56
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92772
- Gene
- CDKL2
- Ensembl
- ENSG00000138769
- Chromosome
- 4
- Canonical length
- 493 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centrosome
OverviewNCBI Gene
This gene product is a member of a large family of CDC2-related serine/threonine protein kinases. It accumulates primarily in the cytoplasm, with lower levels in the nucleus. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
493 residues, UniProt reviewed canonical sequence.
>Q92772|CDKL2
1 MEKYENLGLV GEGSYGMVMK CRNKDTGRIV AIKKFLESDD DKMVKKIAMR EIKLLKQLRH
61 ENLVNLLEVC KKKKRWYLVF EFVDHTILDD LELFPNGLDY QVVQKYLFQI INGIGFCHSH
121 NIIHRDIKPE NILVSQSGVV KLCDFGFART LAAPGEVYTD YVATRWYRAP ELLVGDVKYG
181 KAVDVWAIGC LVTEMFMGEP LFPGDSDIDQ LYHIMMCLGN LIPRHQELFN KNPVFAGVRL
241 PEIKEREPLE RRYPKLSEVV IDLAKKCLHI DPDKRPFCAE LLHHDFFQMD GFAERFSQEL
301 QLKVQKDARN VSLSKKSQNR KKEKEKDDSL VEERKTLVVQ DTNADPKIKD YKLFKIKGSK
361 IDGEKAEKGN RASNASCLHD SRTSHNKIVP STSLKDCSNV SVDHTRNPSV AIPPLTHNLS
421 AVAPSINSGM GTETIPIQGY RVDEKTKKCS IPFVKPNRHS PSGIYNINVT TLVSGPPLSD
481 DSGADLPQME HQHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDKL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- testis: 11 nTPM
- retina: 8.9 nTPM
- cerebral cortex: 6.4 nTPM
- choroid plexus: 6.2 nTPM
- cerebellum: 5.9 nTPM
- hypothalamus: 5.8 nTPM
Single-cell type
- late primary spermatocytes: 182 nCPM
- alveolar cells type 2: 103 nCPM
- choroid plexus epithelial cells: 87 nCPM
- retinal ganglion cells: 81 nCPM
- loop of henle epithelial cells: 73 nCPM
- epididymal efferent duct ciliated cells: 62 nCPM
Immune cell
- memory CD8 T-cell: 0.1 nTPM
- T-reg: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 19 nTPM
- white matter: 17 nTPM
- cerebral cortex: 14 nTPM
- basal ganglia: 14 nTPM
- pons: 14 nTPM
- hypothalamus: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDKL2.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 84 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- CDKL2-related condition
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.25
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- cyclin-dependent protein serine/threonine kinase activity
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDKL2 as an antibody target. Whether an autoantibody or antibody against CDKL2 could matter depends on whether native CDKL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDKL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDKL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...